Unprecedented demand for flu shots in Australia forced health authorities to ration the vaccines late last month amid a national influenza vaccine shortage.

Disease surveillance studies are an important tool for determining the burden of a disease. By knowing how many people are impacted by a disease – and just as importantly, knowing where and at what age people are most effected – decision-makers can create informed and targeted health policy.

The worst U.S. flu season in a decade appears to be winding down, but the truth is, it’s always flu season. Even now, as Americans begin to put away the thermometers, hand sanitizers and cough drops, researchers are preparing for the next flu season. As early as February, they began trying to predict which influenza strains will dominate so they can create the right cocktail for next season’s vaccine.

Statement on New Universal Flu Vaccine Development Grand Challenge

WASHINGTON, D.C. – April 27, 2018 – The new $12 million Ending the Pandemic Threat: A Grand Challenge for Universal Influenza Vaccine Development from the Bill & Melinda Gates Foundation and Lucy and Larry Page is an important and necessary step toward finding a game-changing solution to end the threat of flu, according to experts at the Sabin Vaccine Institute (Sabin), a leading advocate for expanding vaccine access and uptake across the world. This challenge invites researchers from any discipline to submit innovative ideas for safe, effective, affordable flu vaccines.
Last night, more than one hundred guests joined together to honor Dr. Paul Offit as the recipient of the 2018 Sabin Gold Medal. Colleagues, family, friends and peers gathered at the National Academy of Sciences building in Washington, D.C., to celebrate Dr. Offit’s contributions to immunization, including his achievements as the co-inventor of an oral rotavirus vaccine and his leadership as a vocal and dedicated advocate for immunization.
Every year, the Albert B. Sabin Gold Medal is given to a distinguished member of the public health community who has made extraordinary contributions in the field of vaccinology or a complementary field. This year's award will honor Dr. Paul Offit for his contributions as co-inventor of an oral rotavirus vaccine and his leadership as one of the United States’ most vocal and dedicated advocates for immunization.

Dr. Paul Offit Receives 2018 Albert B. Sabin Gold Medal

WASHINGTON, D.C. – April 24, 2018 – Tonight, the Sabin Vaccine Institute (Sabin) will honor Dr. Paul Offit with the 2018 Albert B. Sabin Gold Medal. Sabin will recognize Dr. Offit for his contributions as co-inventor of an oral rotavirus vaccine and his leadership as one of the United States’ most vocal and dedicated advocates for immunization.

Pages